Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances
Summary
Lactate and its mediated modification, lactylation, are receiving increasing attention in the field of tumor biology. This review provides a comprehensive overview of the mechanistic involvement of lactate and lactylation in key oncogenic processes, such as tumor initiation, proliferation, invasion, metastasis, recurrence, and drug resistance. Rather than being a passive byproduct of glycolysis, lactate actively shapes the tumor microenvironment (TME), modulates immune responses, drives me
Content
# Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances
*Published: 2026 May 21*
Lactate and its mediated modification, lactylation, are receiving increasing
attention in the field of tumor biology. This review provides a comprehensive
overview of the mechanistic involvement of lactate and lactylation in key
oncogenic processes, such as tumor initiation, proliferation, invasion,
metastasis, recurrence, and drug resistance. Rather than being a passive
byproduct of glycolysis, lactate actively shapes the tumor microenvironment
(TME), modulates immune responses, drives metabolic adaptation, and influences
epigenetic and transcriptomic regulation. Lactylation, as a novel epigenetic
mechanism, links cellular metabolism with gene expression by modifying histone
and nonhistone proteins, thereby regulating chromatin accessibility, immune
evasion, and DNA repair. Notably, this article proposes a new perspective:
lactate accumulation in certain tumors may constitute an adaptive metabolic
strategy rather than a passive consequence of altered metabolism. This paradigm
challenges the traditional perception of lactate as a metabolic waste, instead
proposing its dual function as both a signaling molecule and a strategic
modulator of tumor progression. The interplay of lactate-mediated signaling
pathways, such as the PI3K/AKT, Hippo, Wnt, MAPK, and JAK/STAT pathways, further
underscores the role of lactate in cancer progression. This review also explores
therapeutic opportunities targeting lactate metabolism and lactylation,
including inhibitors of LDH, MCTs, and lactylation-modifying enzymes, as well as
the synergistic potential of combining lactate-targeted approaches with
chemotherapy, immunotherapy, and targeted therapy. Overall, this review provides
an integrative overview of lactate-mediated mechanisms and highlights their
potential as targets for metabolism-oriented therapeutic interventions in
oncology.
DOI: 10.1038/s41392-026-02672-x